Indene derivatives as pharmaceutical agents

Details for Australian Patent Application No. 2004229598 (hide)

Owner Aquinox Pharmaceuticals Inc.

Inventors Han, Kang; Noren, Bradley; Zhou, Yuanlin; Raymond, Jeffery R.; Yee, James Gee Ken; He, Yuehua

Agent Davies Collison Cave

Pub. Number AU-B-2004229598

PCT Pub. Number WO2004/092100

Priority 60/463,216 15.04.03 US

Filing date 15 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 20 January 2011

International Classifications

C07C 35/21 (1970.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring

C07C 35/32 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring

C07C 69/013 (2006.01) Esters of carboxylic acids

C07C 69/03 (2006.01) Esters of carboxylic acids

C07C 311/04 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 233/54 (1970.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/56 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 295/096 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/66 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 317/66 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092100 Priority application(s): WO2004/092100

23 December 2010 Assignment before Grant

  Inflazyme Pharmaceuticals Ltd. The application has been assigned to Aquinox Pharmaceauticals Inc.

6 January 2011 Corrigenda

  Assignments Before Grant, Section 113 - 2004 Under the name Aquinox Pharmaceauticals Inc.. Application no. 2004229598, under INID (71), correct the applicant name to Aquinox Pharmaceuticals Inc.

20 January 2011 Application Accepted

  Published as AU-B-2004229598

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229604-Container

2004229597-SARS-related proteins